Publications

Shin S, Ko H, Kim CH, Yoon BK, Son S, Lee JA, Shin JM, Lee J, Song SH, Jackman JA, Park JH
Curvature-sensing peptide inhibits tumour-derived exosomes for enhanced cancer immunotherapy
Nature Materials 2023;22,656

ES Lee, Shin JM
Natural-product-inspired approaches for cancer diagnosis and therapy
Pharmaceutics 2022;14(9),1884

Lee JA*, Shin JM*, Song SH, Kim CH, Son S, Shin S, Park JH
Recruitment of dendritic cells using ‘find-me’ signaling microparticles for personalized cancer immunotherapy
Biomaterials 2022;282;121412 (*: contributed equally)

Kim S, Heo R, Song SH, Song KH, Shin JM, Oh SJ, Lee HJ, Chung JE, Park JH, Kim TW
PD-L1 siRNA-hyaluronic acid conjugate for dual-targeted cancer immunotherapy
Journal of Controlled Release. 2022;346:226-239

Shin JM*, Lee CH*, Son S, Kim CH, Lee JA, Ko H, Shin S, Song SH, Park SS, Bae JH, Park JM, Cheo EJ, Baek MC, Park JH
Sulfisoxazole elicits robust antitumor immune response along with immune checkpoint therapy by inhibiting exosomal PD-L1
Advanced Science 2021, 2103245 (*: contributed equally)

Son S*, Shin JM*, Shin S, Kim CH, Lee JA, Ko H, Lee ES, Park JH
Repurposing macitentan with nanoparticle synergistically potentiates immune checkpoint therapy by modulating tumor microenvironment
Biomaterials 2021;276;121058 (*: contributed equally)

Shin JM*, Choi GH*, Song SH, Ko H, Lee ES, Lee JA, Yoo PJ, Park JH
Metal-phenolic network-coated hyaluronic acid nanoparticles for pH-responsive drug delivery
Pharmaceutics 2019;11(12);636 (*: contributed equally)

Lee ES*, Shin JM*, Son S, Ko H, Um W, Song SH, Lee JA, and Park JH
Recent advances in polymeric nanomedicines for cancer immunotherapy
Advanced Healthcare Materials 2019;8;1801320 (*: contributed equally)

Shin JM*, Song SH*, Vijayakameswara RN, Lee ES, Ko H, Park JH
A carboxymethyl dextran-based polymeric conjugate as the antigen carrier for cancer immunotherapy
Biomaterials Research 2018;22;21-27 (*: contributed equally)

Shin JM*, Oh SJ*, Kwon S, Deepagan VG, Lee M, Song SH, Lee HJ, Kim S, Song KH, Kim TW, Park JH
A PEGylated hyaluronic acid conjugate for targeted cancer immunotherapy
Journal of Controlled Release 2017;267:181-190 (*: contributed equally)

Shin JM*, Hwang SR*, Heo R, Saravanakumar G, Park JH
Amphiphilic hyaluronic acid derivative with the bioreducible bond: Synthesis and its implication for intracellular drug delivery
Polymer Degradation and Stability 2014;109:398-404 (*: contributed equally)

10. Shin JM*, Kim SH*, Thambi T, You DG, Jeon J, Lee JO, Chung BY, Jo DG, Park JH
A hyaluronic acid-methotrexate conjugate for targeted therapy of rheumatoid arthritis
Chemical Communications 2014;50:7632-7635 (*: contributed equally)